Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Sofosbuvir

An antiviral that blocks the hepatitis C virus polymerase, approved in 2013. Combined with other antivirals it cures the infection in over 90% of patients in about three months. This family brings together the active ingredient, metabolites, labelled standards and other impurities.

Did you know?It turned hepatitis C, once treated with months of interferon and many side effects, into a disease cured with tablets.

SofosbuvirGo to the active ingredient →
SofosbuvirActive ingredientSofosbuvirCat. No. P-S056-001CAS 1190307-88-0
Sofosbuvir-d6Isotopically labelledSofosbuvir-d6Cat. No. P-S056-010CAS 1868135-06-1

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.